Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus

5 Jan 2022

Abstract excerpt

Contemporary SARS-Cov-2 pandemic, besides its dramatic global influence on the human race including health care systems, economies, and political decisions, opened a window for the global experiment with human vaccination employing novel injectable vaccines providing predominantly specific IgG response with little knowledge of their impact on the mucosal immunity. However, it is widely accepted that protection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Vaccine Coverage and Hesitancy
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35145407
DOI: 10.3389/fphar.2021.807256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 VirusPMID 35145407Read ↗

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and ProtectionSemantic proximity Read ↗

Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacteriumSemantic proximity Read ↗

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in miceSemantic proximity Read ↗

Development of a Conserved Chimeric Vaccine for Induction of Strong Immune Response against Staphylococcus aureus Using Immunoinformatics ApproachesSemantic proximity Read ↗

An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine AntigenSemantic proximity Read ↗

A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2Semantic proximity Read ↗

Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approachesSemantic proximity Read ↗

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in FerretsSemantic proximity Read ↗

An Integrated Comparative Genomics, Subtractive Proteomics and Immunoinformatics Framework for the Rational Design of a Pan- <i>Salmonella</i> Multi-Epitope VaccineSemantic proximity Read ↗

Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191Semantic proximity Read ↗

A study protocol to prepare an RBD protein for vaccine against COVID-19Semantic proximity Read ↗

Characterization and Protective Efficacy of Type III Secretion Proteins as a Broadly Protective Subunit Vaccine against Salmonella enterica SerotypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.